Naresh Haresh Tanna - 01 Aug 2026 Form 3 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
03 Aug 2026, 07:16:46 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dario Scimeca, Attorney-in-Fact for Naresh Tanna

Key filing fact

Naresh Haresh Tanna filed Form 3 for PRECISION BIOSCIENCES INC (DTIL) on 03 Aug 2026.

Key facts

  • This page summarizes Naresh Haresh Tanna's Form 3 filing for PRECISION BIOSCIENCES INC (DTIL).
  • 0 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 03 Aug 2026, 07:16.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111819 Primary reporting owner

Tanna Naresh Haresh

Relationship
Chief Financial Officer
Address
C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Naresh Tanna
Signature date
03 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DTIL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,575
Date
01 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DTIL holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,561
Exercise price
Footnotes
F1, F2
DTIL holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,105
Exercise price
Footnotes
F2, F3
DTIL holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
Footnotes
F2, F4
DTIL holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
179,340
Exercise price
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On April 18, 2024, the reporting person was granted 16,683 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

Footnote F2

The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.

Footnote F3

On August 22, 2024, the reporting person was granted 33,317 RSUs, which vest in three substantially equal annual installments beginning on January 27, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

Footnote F4

On June 2, 2025, the reporting person was granted 45,000 RSUs, which vest in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

Footnote F5

On June 1, 2026, the reporting person was granted 179,340 RSUs, which vest in three substantially equal annual installments beginning on February 19, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .